Filter
914
Text search:
pocket
guide
Featured
113
278
Language
Document type
531
134
110
59
46
13
10
7
2
2
Countries / Regions
44
41
34
33
32
29
23
22
19
19
15
15
15
13
13
12
11
11
10
10
10
9
9
9
8
8
6
6
6
5
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
350
98
75
56
33
15
8
1
Toolboxes
54
49
45
42
34
33
32
31
30
27
25
24
24
16
14
13
11
11
9
3
1
1
1
“towards quality health and social welfare services”
Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
National Tuberculosis and Leprosy Conrol Programme
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
WHO/CDS/CSR/EDC/99.2 Plague Manual
Epidemiology, Distribution, Surveillance and Control
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
HRH SA 2030 | Draft HR Strategy for the Health Sector: 2012/13 – 2016/17 Consultation Document
Annex 1: Measuring progress towards targets
Annex 2: Modelling the impact of the 90-(90)-90 strategy
Annex 3: Investment packages by country setting
Annex 4: Country strategies
Annex 5: Strategic frameworks for research and development for new tools
Annex 6 : Estimating the cost of the 90-(90)-
...
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed
...
NHSP 2017- 2022 (Final draft)
Accessed November 2017.
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Towards ending tuberculosis and multidrug-resistant tuberculosis.
The END TB Strategy
